ASSET CONTRIBUTION AND SEPARATION AGREEMENT by and between ALLIQUA BIOMEDICAL, INC. and ACQUAMED TECHNOLOGIES, INC. Dated as of May 3, 2019 ASSET CONTRIBUTION AND SEPARATION AGREEMENTAsset Contribution and Separation Agreement • July 25th, 2019 • Adynxx, Inc. • Surgical & medical instruments & apparatus • Delaware
THIS ASSET CONTRIBUTION AND SEPARATION AGREEMENT (this “Agreement”) is entered into as of May 3, 2019, by and among: Alliqua BioMedical, Inc., a Delaware corporation (“Alliqua”), and AquaMed Technologies, Inc., a Delaware corporation (“AquaMed”). Certain capitalized terms used in this Agreement are defined in Exhibit A.
ASSET CONTRIBUTION AND SEPARATION AGREEMENTAsset Contribution and Separation Agreement • November 9th, 2017 • Biotime Inc • Biological products, (no disgnostic substances) • Delaware
[ * ] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.
AGREEMENT AND PLAN OF MERGER by and among AQUAMED TECHNOLOGIES, INC. AQ TOP, LLC and TO PHARMACEUTICALS, LLC Dated as of November 27, 2018Asset Contribution and Separation Agreement • November 28th, 2018 • Alliqua BioMedical, Inc. • Surgical & medical instruments & apparatus • Delaware
THIS AGREEMENT AND PLAN OF MERGER (this “Agreement”) is made and entered into as of November 27, 2018, by and among AquaMed Technologies, Inc., a Delaware corporation (“Parent”), AQ TOP, LLC, a Delaware limited liability company and wholly owned subsidiary of the Parent (“Merger Sub”), and TO Pharmaceuticals LLC, a Delaware limited liability company (the “Company”). Capitalized terms not otherwise defined in this Agreement shall have the respective meanings ascribed to them in Exhibit A.
